UniQure outlines AMT-130 confirmatory study of ~200 patients with May 1, 2027 PDUFA date in focus

uniQure Q3 2026 earnings: AMT-130 wins FDA priority review ahead of May 2027 PDUFA.

CryptoAlerta — análise de criptomoedas e mercado em tempo real